Non-Hodgkin’s lymphomas of the organ of vision (a review of literature)


如何引用文章

全文:

详细

Celebrated worldwide increase in the incidence non-Hodgkin's lymphoma, it is higher in the developed world, where increased more than 50% over the past 20 years and exceeds the rate of growth in the incidence of Hodgkin's lymphoma. Non-Hodgkin's lymphoma of the orbit, the eye and adnexa account for 4,1–8% of all extranodal lymphomas, the pathology of particular interest to oncologists and ophthalmologists. In recent years, much attention is paid to the prognosis of extranodal non-Hodgkin's lymphoma. This paper presents the details of the literature on prognosis non-Hodgkins lymphoma eye and adnexa. Analysis has shown that to date, all of the existing prognostic scales do not represent the full prognosis of primary non-Hodgkin's lymphoma eye and adnexa. This question requires a detailed study.

作者简介

E Guzenko

Офтальмологическая клиническая больница Департамента здравоохранения г. Москвы

Email: labirint76@mail.ru
врач отд-ния онкологии

参考

  1. Бикбов М.М., Габдрахманова А.Ф., Верзакова И.В. Комплексная диагностика заболеваний орбиты. Уфа, 2008; с. 7–35.
  2. Бровкина А.Ф. Болезни орбиты. Руководство для врачей. М.: Медицинское информационное агентство, 2008; с. 66–198. Болезни орбиты. М.: Медицина, 1993; с. 60–6.
  3. Бровкина А.Ф., Вальский В.В., Гусев Г.А. и др. Под ред. А.Ф.Бровкиной. Офтальмоонкология. Руководство для врачей. М.: Медицина, 2002; с. 57–107.
  4. Бровкина А.Ф., Гришина Е.Е. Злокачественная (неходжкинская) лимфома органа зрения. Вестн. офтальмологии. 2009; 1: 58–61.
  5. Волкова М.А., Поддубная И.В. Клиническая онкогематология. Гл. 35. Неходжкинские лимфомы. М.: Медицина, 2007; с. 724–66.
  6. Гончарова О.В., Липатов О.Н. Анализ клинико - морфологических вариантов неходжкинских лимфом. Сиб. онкол. журн. 2009; 5: 35.
  7. Гришина Е.Е. Злокачественные лимфомы органа зрения. Проблемы и перспективы (взгляд офтальмолога). Соврем. онкология. 2007; 8 (4): 27–9.
  8. Гришина Е.Е. Неходжкинские лимфомы органа зрения (лекция). М., 2007; с. 8–16.
  9. Гришина Е.Е. Патогенез внутриглазной лимфомы. Сб. научных трудов научно - практической конференции «Опухоли и опухолеподобные заболевания органа зрения». 2010; с. 31–5.
  10. Давыдов М.И., Аксель Е.М. Заболеваемость злокачественными новообразованиями. М.: Вестн. РОНЦ им. Н.Н.Блохина РАМН, 2011; 22 (Прил. 1) 3: 54–164.
  11. Красильникова Б.Б. Первичные лимфатические опухоли орбиты и придаточного аппарата глаза. Автореф. дис. … канд. мед. наук. М., 2009; с. 60.
  12. Advani R.H., Chen H, Hebermann T.M. et al. Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater then 70 years in an elderly prognostic index (E-IPI). Br J Hematol 2010; 151 (2): 143–51.
  13. Canellos G.P., Lister T.A., Sklar J.L. General aspects of extranodal lymphoma. In the lymphomas. W.Saunders Company 1997; p. 450–78.
  14. Coupland S.E., White V.A., Rootman J et al. A TNM-based clinical staging system of ocular adnexal lymphomas. Iso Meeting 2009; р. 338.
  15. Davis J.L. Intraocular lymphoma: a clinical perspective. Eye Lond 2013; 27 (2); р. 153–62.
  16. Ferry J.A., Fung C.Y., Zukerberg L et al. Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol 2007; 31: 170–84.
  17. Fisson S, Ouakrim H, Touitou V et al. Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis. PLoS One 2013; 8 (2): 12.
  18. Nakauchi Y, Takase H, Sugita S et al. Concurrent administration of intravenous systemic and intravitreal methotrexate for intraocular lymphoma with central nervous system involvement. J Hematol 2010; 92 (1): 179–85.
  19. Hicks D, Mick A. Recurrent subconjunctival hemorrhages leading to the discovery of ocular adnexal lymphoma. Optometry 2010; 81 (10): 528–32.
  20. Jaffe E.S. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematol Am Soc Hematol Educ Program 2009; р. 523–31.
  21. Khalil H.A., de-Keiser R.J., Kluin P.M. et al. Clinical course and pathologic features of conjunctival non - Hodgkin’s lymphoma. A report of six cases. Graefes Arch Clin Exp Ophthalmol 1990; 228 (3): 246–51.
  22. Kim K.M., Yoon D.H., Lee S.G. et al. A case of primary adrenal diffuse large B-cell lymphoma achieving complete remission with rituximab CHOP chemotherapy. J Korean Med Sci 2009; 24 (3): 525–8.
  23. Knowles D.M., Jacobiec F.A., McNally L, Burke J. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjimctiva and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol 1990; 21 (9): 959–73.
  24. Lagoo A.S., Hagerty C, Kim Y et al. Morphologic features of 115 lymphomas of the orbit and ocular adnexa categorized according to the world health organization classification. Arch Pathol Lab Med 2008; 132: 1405–16.
  25. Lim S.H., Kang M, Son J. Extranodal marginal zone B-cell lymphoma of mucosa - associated lymphoid tissue type of the ocular adnexa: retrospective single institution review of 95 patients. Indian J Ophthalmol 2011; 59 (4): 273–7.
  26. McKelvie P.A. Ocular adnexal lymphomas: a review. Adv Anat Pathol 2010; 17 (4): 251–61.
  27. Medeiros L.J., Harmon D.C., Linggood R.M., Harris N.L. Immunohistologic featurs predict clinical behavior of orbital and conjunctival lymphoid infiltrates. Blood 1989; 74: 102–229.
  28. Meunier J, Lumbroso Le Rouic L, Dendale R et al. Conjunctival low - grade non-Hodgkin’s lymphoma: a large single - center study of initial characteristics, natural history and prognostic factors. Leukemia Lymphoma 2006; 47 (7): 1295–305.
  29. Mikami R, Nakayama H, Goto H, Kimura K et al. Preliminary results of radiotherapy for primary intraocular non - Hodgkin's lymphoma. Leuk Lymphoma 2013; р. 24.
  30. Nakata M, Matsuno Y, Katsumata N et al. Histology according to the Revised European - American Lymphoma classification significantly predicts the prognosis of ocular adnexal lymphoma. Leuk Lymphoma 1999; 32 (5–6): 533–43.
  31. Pine R.R., Clark J.D., Sokol J.A. CD56 Negative extranodal NK/T-cell lymphoma of the orbit mimicking orbital cellulites. J Orbit 2013; 32 (1): 45–8.
  32. Prall F.R., Hink E.M., Liang X, Durairaj V.D. Rapid onset proptosisand vision loss as the initial presentation of Burkitt lymphoma. Ophthalmic Surg Lasers Imaging 2008; 39 (4): 331–4.
  33. Sebn L.H., Berry B, Ghhanabhai M et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 2007; 109 (5): 1857–67.
  34. Shikishima K, Kawai K, Kitahara K. Pathological evaluation of orbital tumours in Japan: analysis of a large case series and 1379 cases reported in the Japanese literature. Clin Exper Ophthalmol 2006; 34 (3): 239–44.
  35. Silva C.P., Domingues M.A., Schelini S.A. et al. Non - Hodgkin orbital lymphoma: case report. Arq Bras Ophthalmol 2008; 71 (2): 278–81.
  36. Stacy R.C., Jakobiec F.A., Herwig M.C. et al. Diffuse large B-cell lymphoma of the orbit: clinicopathologic, immunohistochemical, and prognostic features of 20 cases. Am J Ophthalmol 2012; 154 (1): 87–98.
  37. Talaulikar D, Shadbolt B, Dablstrom J.E. et al. Routin use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI). J Hematol Oncol 2009; 22: 2–49.
  38. Vitolo U, Ferreri A.J., Zucca E. Primary testicular lymphoma. Crit Rev Oncol Hematol 2008; 65 (2): 183–9.
  39. Vollmer L. The diagnosis and management of ocular lymphoma. Optom Vis Sci 2013; 90 (2): 56–62.
  40. Watkins L.M., Carter K.D., Nerad J.A. Ocular adnexal lymphoma of the extra ocular muscles: case series from the University of Iowa and review of the literature. Ophthal Plast Reconst Surg 2011; 27 (6): 471–6.
  41. Yang D.T., Dunphy C.H., Tripp S.R. et al. Nodular Lymphocyte predominant Hodgkin lymphoma at atypical locations may be associated with increased numbers of large cells and a diffuse histologic component. Am J Hematol 2008; 83: 218–21.

版权所有 © Consilium Medicum, 2013

Creative Commons License
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。
 


##common.cookie##